testicular discomfort. Physical examination revealed enlarged firm testicles and several non-confluent, erythematous, slightly raised papules on the torso. A complete blood count revealed pancytopenia (WBCs: 1.3 × 10 9 /μL, absolute neutrophil count: 0.3 × 10 9 /μL, hemoglobin: 9.4 g/dL and platelets: 98 × 10 9 /μL) and evidence of spontaneous tumor lysis (lactate dehydrogenase: 5760 U/L). Examination of a peripheral blood smear showed occasional nucleated RBCs and 2% blasts, which were positive for CD33 and CD117 on flow cytometry. A whole-body positron emission tomography scan revealed diffusely increased uptake in the testicles and no marrow uptake ( Figure 1a) . A bone marrow biopsy showed sheets of ill-defined necrotic cells occupying the entire marrow in an amorphous eosinophilic background and with preserved cortical bone (Figure 1b) . Repeat bone marrow biopsy showed similar findings. Due to extensive necrosis, karyotype and cytogenetic analyses were unsuccessful. Examination of the cerebrospinal fluid was unremarkable. Right orchiectomy demonstrated diffuse infiltration by sheets of large neoplastic cells with moderate amounts of eosinophilic cytoplasm and round nuclei, with dispersed chromatin and prominent nucleoli. Mitotic figures were numerous. On immunohistochemistry (IHC) and flow cytometry, neoplastic cells were positive for CD33, CD56, CD68, CD117 and lysozyme, and negative for CD34 and TdT. Cytogenetic analysis on the testicular biopsy specimen revealed a hyperdiploid male karyotype 48,XY,+8,+8,t(9;11)(p22;q23) [6] with MLL gene rearrangement on fluorescence in situ hybridization. A skin biopsy was consistent with leukemia cutis and showed mid-dermal aggregates of large mononuclear cells with prominent nucleoli. These cells were positive on IHC for CD56 and CD68, and negative for myeloperoxidase, CD34 and TdT. A final diagnosis of MLL-rearranged AML presenting with extensive BMN, leukemia cutis and testicular involvement was established.
The patient received induction chemotherapy using the CLAM (cladribine, cytarabine and mitoxantrone) regimen, followed by radiation (total dose: 2400 cGy) to the scrotum and left testicle, and one cycle of consolidation with high-dose cytarabine (3000 mg/m 2 every 12 h for six doses). A complete resolution of skin lesions and testicular swelling was noted. However, extensive BMN persisted throughout treatment. He then underwent a matched unrelated donor allo-HSCT with G-CSF mobilized PBSCs and myeloablative conditioning using fludarabine and fractionated TBI (1200 cGy). For GvHD prophylaxis, he received high-dose cyclophosphamide at a dose of 50 mg/kg on days +3 and +4 along with tacrolimus (continued until day +180) and mycophenolate mofetil (stopped on day +35). His post-transplant course was unremarkable with no evidence of acute or chronic GvHD. On day +180 post-transplant follow-up visit, his counts and physical examination were normal and donor chimerism was 100%. Interestingly, although normal hematopoietic islands were observed in some areas of the marrow (Figure 1c ), significant necrosis continued to be present in neighboring areas (Figure 1d) .
Badar et al. recently reported the largest retrospective series of patients with AML and BMN. The incidence of BMN at diagnosis among their 1051 patients was 2.4%. Furthermore, extensive BMN was a poor prognostic sign, associated with low CR rates and short median event-free survival of only 3.7 months. 3 Importantly, 68% of patients with BMN in this series failed to achieve a CR, suggesting high rates of primary refractoriness and aggressive disease. Poor-risk cytogenetics were more common among patients with BMN than those without BMN (44% vs 31%, respectively), although the difference did not reach statistical significance (P = 0.19). One would predict that patients with AML and extensive BMN likely benefit from allo-HSCT due to their otherwise poor prognosis. Our finding of persistent necrosis despite successful engraftment and normal hematopoiesis following allo-HSCT are consistent with the recent observation that in addition to axial niches, the appendicular marrow is also colonized by allogeneic hematopoietic stem cells. 4 By occupying areas of the marrow abandoned in normal individuals, allogeneic stem cells can restore normal hematopoiesis despite the presence of residual necrosis in the axial marrow.
